EDIT
Editas Medicine, Inc.
+0.17 (+6.46%)2.89USD1.6M成交股數443M市值–本益比(近四季)9.4股價營收比+232.3%營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 5 · 34K · 3 |
| 其中 10b5-1 計畫賣出 | 5 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 79K |
| 近 180 天 淨額 | −79K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 09-04 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 5.1K | 3.04 | 16K | 243K | SEC |
| 2026-09-03 | 09-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 709 | 3.04 | 2K | 61.7K | SEC |
| 2026-09-03 | 09-04 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 453 | 3.04 | 1K | 13.8K | SEC |
| 2026-08-03 | 08-05 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 678 | 2.58 | 2K | 14.3K | SEC |
| 2026-07-28 | 07-29 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 4.9K | 2.67 | 13K | 62.4K | SEC |
| 2026-06-03 | 06-05 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 15.4K | 2.70 | 42K | 248K | SEC |
| 2026-06-03 | 06-05 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 731 | 2.70 | 2K | 67.3K | SEC |
| 2026-06-03 | 06-05 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 464 | 2.70 | 1K | 15.0K | SEC |
| 2026-03-03 | 03-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 749 | 2.02 | 2K | 68.0K | SEC |
| 2026-03-03 | 03-04 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 5.4K | 2.02 | 11K | 264K | SEC |
| 2026-03-03 | 03-04 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 474 | 2.02 | 957.48 | 15.4K | SEC |
| 2025-12-03 | 12-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 713 | 2.15 | 2K | 68.8K | SEC |
| 2025-12-03 | 12-04 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 461 | 2.15 | 991.15 | 15.9K | SEC |
| 2025-12-03 | 12-04 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 5.6K | 2.15 | 12K | 269K | SEC |
| 2025-09-03 | 09-04 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 458 | 2.60 | 1K | 16.4K | SEC |
| 2025-09-03 | 09-04 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 5.6K | 2.60 | 15K | 275K | SEC |
| 2025-09-03 | 09-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 710 | 2.60 | 2K | 69.5K | SEC |
| 2025-08-07 | 08-08 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 679 | 2.58 | 2K | 16.8K | SEC |
| 2025-07-31 | 08-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 5.1K | 2.49 | 13K | 64.4K | SEC |
| 2025-06-03 | 06-04 | Parison Amy | SVP, Chief Financial Officer | S 公開市場賣出(10b5-1) | 446 | 1.72 | 767.12 | 17.5K | SEC |
| 2025-06-03 | 06-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 726 | 1.72 | 1K | 69.5K | SEC |
| 2025-06-03 | 06-04 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 15.2K | 1.72 | 26K | 280K | SEC |
| 2025-03-04 | 03-05 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 16.6K | 1.71 | 28K | 295K | SEC |
| 2025-03-04 | 03-05 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 2.9K | 1.71 | 5K | 70.2K | SEC |
| 2025-03-04 | 03-05 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 4.1K | 1.71 | 7K | 113K | SEC |
| 2024-12-03 | 12-05 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 541 | 2.08 | 1K | 133K | SEC |
| 2024-12-03 | 12-05 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 1.6K | 2.08 | 3K | 312K | SEC |
| 2024-09-04 | 09-06 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 518 | 3.42 | 2K | 134K | SEC |
| 2024-09-04 | 09-06 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 1.6K | 3.42 | 5K | 314K | SEC |
| 2024-07-25 | 07-26 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出(10b5-1) | 11.9K | 5.42 | 64K | 73.1K | SEC |
| 2024-07-19 | 07-22 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 6.6K | 5.21 | 34K | 134K | SEC |
| 2024-06-04 | 06-06 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 511 | 5.50 | 3K | 141K | SEC |
| 2024-06-04 | 06-06 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 12.2K | 5.50 | 67K | 315K | SEC |
| 2024-05-20 | 05-22 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 22.3K | 5.61 | 125K | 117K | SEC |
| 2024-05-13 | 05-14 | Hopfield Jessica | Director | P 公開市場買進 | 45.0K | 5.64 | 254K | 67.7K | SEC |
| 2024-03-05 | 03-05 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 77.8K | 9.42 | 733K | 327K | SEC |
| 2024-03-04 | 03-05 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 20.3K | 9.42 | 191K | 142K | SEC |
| 2024-03-02 | 03-05 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A 獲配股票 | 50.9K | – | – | 123K | SEC |
| 2024-03-02 | 03-05 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A 獲配股票 | 35.3K | – | – | 113K | SEC |
| 2024-03-02 | 03-05 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 15.1K | – | – | 85.0K | SEC |
| 2024-03-02 | 03-05 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 24.8K | – | – | 70.0K | SEC |
| 2024-03-02 | 03-05 | O'Neill Gilmore Neil | CEO | A 獲配股票 | 72.2K | – | – | 405K | SEC |
| 2024-03-02 | 03-05 | O'Neill Gilmore Neil | CEO | A 獲配股票 | 72.2K | – | – | 333K | SEC |
| 2024-03-02 | 03-05 | O'Neill Gilmore Neil | CEO | A 獲配股票 | 131K | – | – | 261K | SEC |
| 2024-03-02 | 03-05 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A 獲配股票 | 19.5K | – | – | 162K | SEC |
| 2024-03-02 | 03-05 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A 獲配股票 | 26.0K | – | – | 139K | SEC |
| 2024-03-02 | 03-05 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A 獲配股票 | 19.5K | – | – | 142K | SEC |
| 2023-12-05 | 12-07 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 103 | 10.90 | 1K | 74.8K | SEC |
| 2023-11-14 | 11-16 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 695 | 8.21 | 6K | 74.9K | SEC |
| 2023-11-07 | 11-09 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 139 | 8.40 | 1K | 75.6K | SEC |
| 2023-09-06 | 09-07 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 103 | 8.82 | 908.46 | 75.7K | SEC |
| 2023-08-11 | 08-15 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 702 | 8.59 | 6K | 75.8K | SEC |
| 2023-08-08 | 08-10 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 141 | 8.39 | 1K | 76.5K | SEC |
| 2023-07-24 | 07-25 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | A 獲配股票 | 45.2K | – | – | 45.2K | SEC |
| 2023-07-19 | 07-21 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 4.3K | 8.80 | 38K | 72.1K | SEC |
| 2023-06-05 | 06-07 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 105 | 9.50 | 997.50 | 76.7K | SEC |
| 2023-06-05 | 06-07 | O'Neill Gilmore Neil | CEO | S 公開市場賣出(10b5-1) | 6.5K | 9.50 | 62K | 130K | SEC |
| 2023-05-17 | 05-18 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | A 獲配股票 | 77.9K | – | – | 77.9K | SEC |
| 2023-05-11 | 05-15 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 949 | 9.87 | 9K | 107K | SEC |
| 2023-05-11 | 05-15 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 668 | 9.87 | 7K | 76.8K | SEC |
| 2023-05-09 | 05-11 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出(10b5-1) | 135 | 9.51 | 1K | 77.4K | SEC |
| 2023-03-03 | 03-06 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出 | 101 | 8.89 | 897.89 | 77.6K | SEC |
| 2023-03-03 | 03-06 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 184 | 8.89 | 2K | 108K | SEC |
| 2023-03-02 | 03-06 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A 獲配股票 | 18.0K | – | – | 76.4K | SEC |
| 2023-03-02 | 03-06 | O'Neill Gilmore Neil | CEO | A 獲配股票 | 50.0K | – | – | 137K | SEC |
| 2023-03-02 | 03-06 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | A 獲配股票 | 31.5K | – | – | 108K | SEC |
| 2023-03-02 | 03-06 | Eaton Bruce | EVP, CBO AND CTO | A 獲配股票 | 16.7K | – | – | 77.7K | SEC |
| 2023-02-13 | 02-15 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出 | 3.3K | 9.67 | 32K | 61.0K | SEC |
| 2023-02-13 | 02-15 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 4.3K | 9.67 | 41K | 76.2K | SEC |
| 2023-02-13 | 02-15 | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 2.8K | 9.67 | 27K | 65.6K | SEC |
| 2023-02-07 | 02-09 | Eaton Bruce | EVP, CBO AND CTO | S 公開市場賣出 | 346 | 11.10 | 4K | 64.3K | SEC |
| 2023-01-10 | 01-12 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 1.8K | 8.16 | 14K | 80.5K | SEC |
| 2022-12-05 | 12-06 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S 公開市場賣出 | 102 | 10.23 | 1K | 64.6K | SEC |
| 2022-12-05 | 12-06 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 193 | 10.23 | 2K | 82.3K | SEC |
| 2022-11-08 | 11-09 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S 公開市場賣出 | 289 | 11.02 | 3K | 64.7K | SEC |
| 2022-09-06 | 09-08 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | S 公開市場賣出 | 192 | 15.01 | 3K | 82.5K | SEC |
| 2022-09-06 | 09-08 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S 公開市場賣出 | 101 | 15.01 | 2K | 65.0K | SEC |
| 2022-08-09 | 08-10 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | S 公開市場賣出 | 293 | 18.60 | 5K | 65.1K | SEC |
| 2022-07-18 | 07-20 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | A 獲配股票 | 58.4K | – | – | 58.4K | SEC |
| 2022-06-15 | 06-16 | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | S 公開市場賣出 | 5.1K | 10.06 | 52K | 68.3K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 11.1M | 36.0M | 新進 | 新進 |
| BlackRock, Inc. | 10.6M | 34.3M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 8.9M | 28.8M | 新進 | 新進 |
| Commodore Capital LP | 8.9M | 28.8M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 8.9M | 28.8M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | 19.9M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 5.6M | 18.1M | 新進 | 新進 |
| Opaleye Management Inc. | 3.9M | 12.5M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | 11.7M | 新進 | 新進 |
| Woodline Partners LP | 3.6M | 11.5M | 新進 | 新進 |
| Vivo Capital, LLC | 3.6M | 11.5M | 新進 | 新進 |
| GordonMD Global Investments LP | 3.1M | 10.1M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 2.6M | 8.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6M | 8.3M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 2.5M | 8.0M | 新進 | 新進 |
| Logos Global Management LP | 2.2M | 7.2M | 新進 | 新進 |
| STATE STREET CORP | 2.2M | 7.1M | 新進 | 新進 |
| MARSHALL WACE, LLP | 2.0M | 6.6M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 1.9M | 6.2M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.9M | 6.0M | 新進 | 新進 |
| Nantahala Capital Management, LLC | 1.7M | 5.5M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 1.6M | 5.1M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.3M | 4.3M | 新進 | 新進 |
| Seven Fleet Capital Management LP | 1.3M | 4.3M | 新進 | 新進 |
| RAYMOND JAMES FINANCIAL INC | 1.3M | 4.3M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 215 +7 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 215 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 120M · 78.3% |
| 合計季末市值 | 383M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 30.2M |
|---|---|
| 與上期比 | +22.5% |
| 佔流通股數 | 19.69% |
| 日均成交量 | 3.4M |
| 回補天數 | 9.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 30.2M | +22.5% | 19.69% | 3.4M | 9.0 |
| 2026-08-14 | 24.7M | +5.2% | 16.07% | 1.7M | 14.6 |
| 2026-07-31 | 23.5M | +5.7% | 15.28% | 1.3M | 18.2 |
| 2026-07-15 | 22.2M | -1.2% | 14.45% | 2.8M | 8.0 |
| 2026-06-30 | 22.5M | +22.0% | 14.63% | 3.1M | 7.2 |
| 2026-06-15 | 18.4M | +22.2% | 11.99% | 2.4M | 7.7 |
| 2026-05-29 | 15.1M | +57.6% | 9.81% | 4.5M | 3.4 |
| 2026-05-15 | 9.6M | -4.5% | 6.23% | 1.1M | 8.6 |
| 2026-04-30 | 10.0M | -8.3% | 6.52% | 1.4M | 7.1 |
| 2026-04-15 | 10.9M | -8.6% | 7.11% | 1.7M | 6.5 |
| 2026-03-31 | 11.9M | +3.6% | 7.78% | 1.4M | 8.6 |
| 2026-03-13 | 11.5M | -3.1% | 7.50% | 2.3M | 5.1 |
| 2026-02-27 | 11.9M | +1.2% | 7.74% | 1.4M | 8.2 |
| 2026-02-13 | 11.7M | +2.5% | 7.65% | 1.5M | 8.0 |
| 2026-01-30 | 11.5M | -3.1% | 7.46% | 1.9M | 6.1 |
| 2026-01-15 | 11.8M | +4.5% | 7.70% | 2.0M | 6.0 |
| 2025-12-31 | 11.3M | +1.5% | 7.37% | 1.7M | 6.5 |
| 2025-12-15 | 11.2M | +5.5% | 7.26% | 1.8M | 6.4 |
| 2025-11-28 | 10.6M | +5.6% | 6.88% | 1.3M | 7.9 |
| 2025-11-14 | 10.0M | +15.5% | 6.52% | 2.0M | 5.0 |
| 2025-10-31 | 8.7M | +13.7% | 5.64% | 2.9M | 3.0 |
| 2025-10-15 | 7.6M | +2.2% | 4.96% | 3.5M | 2.2 |
| 2025-09-30 | 7.5M | -1.4% | 4.85% | 3.2M | 2.4 |
| 2025-09-15 | 7.6M | -3.3% | 4.92% | 1.4M | 5.4 |
| 2025-08-29 | 7.8M | -4.7% | 5.09% | 1.1M | 7.3 |
| 2025-08-15 | 8.2M | +4.5% | 5.34% | 2.3M | 3.6 |